Aeromonas Infections in Humans—Antibiotic Resistance and Treatment Options
Pathogens · 14.11.2025 · 14 (11) · 1161
DOI: 10.3390/pathogens14111161 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 14.11.2025. Verfasst von Noelia Calvo Sánchez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Area de Microbiología, Complejo Hospitalario Universitario de Orense, 32005 Ourense, Spain. Hauptthemen laut MEDLINE: Aeromonas, Gram-Negative Bacterial Infections, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Management Agency (Agencia de Gestión de la Investigación, AGI) of the University of Salamanca, the Research Management Agency (Agencia de Gestión de la Investigación, AGI) of the University of Salamanca.
Abstract (Originalsprache)
The genus Aeromonas is widely distributed in aquatic environments, where it is a frequent fish pathogen. It has also been described in association with human infections, with most cases caused by A. caviae, A. veronii biovar sobria, and A. hydrophila. More recently, A. dhakensis has emerged as an increasingly important human pathogen. Transmission occurs primarily through ingestion or contacts with aquatic sources, or by consuming contaminated food, particularly from aquatic origins. Growing resistance in Aeromonas has been reported for penicillins (including their combinations with classical β-lactamase inhibitors), cephalosporins, and carbapenems. Among the β-lactam antibiotics, only fourth-generation cephalosporins remain almost uniformly active. Furthermore, the co-occurrence of resistance genes for third-generation cephalosporins and carbapenems within the same isolates is increasing. Recently, the presence of mobile genes conferring colistin resistance has also been documented, with resistance rates sometimes exceeding 30%. This evolution of colistin resistance is likely linked to its use in aquaculture, and together with the rise in β-lactam resistance, may be transforming Aeromonas into a significant reservoir of resistance genes that could potentially be transferred to species more commonly associated with human infections, such as the Enterobacterales.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Area de Microbiología, Complejo Hospitalario Universitario de Orense, 32005 Ourense, Spain.
- Servicio de Microbiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, SACYL, CSIC, 37007 Salamanca, Spain.
- Departamento de Ciencias Biomédicas y del Diagnóstico, Servicio de Microbiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, SACYL, CSIC, 37…
ORCID-Profile: Laura Sancha Domínguez, Ana Cotos Suárez, Juan Luis Muñoz Bellido
Förderung
- Research Management Agency (Agencia de Gestión de la Investigación, AGI) of the University of Salamanca
- the Research Management Agency (Agencia de Gestión de la Investigación, AGI) of the University of Salamanca
Zitieren
APA
Calvo Sánchez, N., Sancha Domínguez, L., Cotos Suárez, A., & Muñoz Bellido, J. L. (2025). Aeromonas Infections in Humans—Antibiotic Resistance and Treatment Options. Pathogens, 14(11), 1161. https://doi.org/10.3390/pathogens14111161
Vancouver
Calvo Sánchez N, Sancha Domínguez L, Cotos Suárez A, Muñoz Bellido JL. Aeromonas Infections in Humans—Antibiotic Resistance and Treatment Options. Pathogens. 2025;14(11):1161. doi:10.3390/pathogens14111161
BibTeX
@article{CalvoSnchez2025,
author = {Calvo Sánchez, Noelia and Sancha Domínguez, Laura and Cotos Suárez, Ana and Muñoz Bellido, Juan Luis},
title = {Aeromonas Infections in Humans—Antibiotic Resistance and Treatment Options},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {11},
pages = {1161},
doi = {10.3390/pathogens14111161}
}
EUVIMED